The effects of GLP-1 analogues in obese, insulin-using type 2 diabetes in relation to eating behaviour

Background Glucagon-like peptide-1 receptor agonists (GLP-1 RA) added to insulin in type 2 diabetes patients have shown to lower body weight, improve glycaemic control and reduce total daily insulin dose in short term studies, although the individual response greatly varies. Objective To evaluate GL...

Descripción completa

Detalles Bibliográficos
Autores principales: de Boer, Stefanie Amarens, Lefrandt, Joop Daniel, Petersen, Japke Frida, Boersma, Hendrikus Hessel, Mulder, Douwe Johannes, Hoogenberg, Klaas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4733138/
https://www.ncbi.nlm.nih.gov/pubmed/26597956
http://dx.doi.org/10.1007/s11096-015-0219-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4733138/
https://www.ncbi.nlm.nih.gov/pubmed/26597956
http://dx.doi.org/10.1007/s11096-015-0219-8

Ejemplares similares